Skip to main content

Investigational site - Clinical research units

proderm has been operating its own Clinical Research Unit in Schenefeld/Hamburg - Germany. Since 1994 we are offering our extensive dermatology expertise, high-quality data and an ongoing success story in recruitment of subjects in our Headquarters in Schenefeld and since 2018 also in our additional Unit in Elmshorn 40 km north-west of Hamburg. The proderm clinical research units can be leveraged as a site in studies managed by our CRO or as an independent site for single or multicenter studies.

Our experienced and regularly trained staff consists of permanently employed and on-demand dermatologists and medical specialists, study nurses and recruitment personnel.


Medical staff:

  • Dermatologists
  • Dentists
  • Ophthalmologists
  • Pediatricians
  • General practitioners
  • Gynecologists
  • ENT physicians

The proderm research units are equipped with highly specialized equipment:

  • Fully air-conditioned (temperature and humidity controlled) examination rooms
  • Extensive equipment for clinical photography
  • Confocal microscopy and LC-OCT
  • In vivo Raman spectroscopy
  • State-of-the-art skin measurement equipment e.g. corneometer, tewameter, skin pH meter
  • Medical examination devices e.g. Yeaple Probe, slit lamp, Tonometer


At our site we run:

  • Safety and efficacy studies
  • Proof-of-Principle/Proof-of-Concept
  • Dose finding studies
  • Pivotal studies
  • Post Market Follow-Up studies (PMCF)
  • Bioequivalence studies (overnight stay in collaboration with Phase I partner unit in close proximity)
  • Antioxidant and biomarker studies
  • Serum and biopsy sampling and analysis


Multi-center studies

To accommodate even larger or very special patient populations, we have established our network of currently more than 40 pre-qualified investigational sites located in the DACH area.

While selecting external study sites, we consider among other things the following criteria:

  • Indication and specialization
  • Qualification (trained in GCP, ISO 14155)
  • Ability of in-time recruitment patients
  • Site description (facilities, team, resources)
  • No competitive studies
  • Accessibility, timely feedback and availability of PI and study team

In addition to these single center or multi-center phase I/II/IV trials or trials with medical devices we also participate in phase III multi-center trials as a study site or managing CRO.